CAS: 1627091-47-7
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | MLi-2 - Bio-X REF: AN-AG01E6U7CAS: 1627091-47-7 | ≥98% | 174.00 €~499.00 € | Tue 21 May 24 |
 | MLi-2 REF: TM-T16115CAS: 1627091-47-7 | 99.33% | 65.00 €~916.00 € | Tue 21 May 24 |
 | MLi-2 REF: 3D-FD157083CAS: 1627091-47-7 | Min. 98 Area-% | 165.00 €~1,296.00 € | Fri 31 May 24 |
 | MLi-2 REF: TR-M425473CAS: 1627091-47-7 | - - - | 20,138.00 € | Tue 02 Jul 24 |
MLi-2 - Bio-X
CAS:1627091-47-7
Formula:
C21H25N5O2
Purity:
≥98%
Color and Shape:
Solid
Molecular weight:
379.4555
Ref: AN-AG01E6U7
| 1mg | 174.00 € | |
| 25mg | 183.00 € | |
| 50mg | 222.00 € | |
| 100mg | 499.00 € |
Estimated delivery in United States, on Tuesday 21 May 2024
MLi-2
CAS:1627091-47-7
MLi-2 is a structurally novel, highly potent, and selective LRRK2 kinase inhibitor with central nervous …
Formula:
C21H25N5O2
Purity:
99.33%
Color and Shape:
Solid
Molecular weight:
379.46
Ref: TM-T16115
| 1mg | 65.00 € | |
| 2mg | 95.00 € | |
| 5mg | 130.00 € | |
| 10mg | 193.00 € | |
| 25mg | 425.00 € | |
| 50mg | 644.00 € | |
| 100mg | 916.00 € | |
| 1ml*10 (DMSO) | 140.00 € |
Estimated delivery in United States, on Tuesday 21 May 2024
MLi-2
CAS:1627091-47-7
A brain-penetrant inhibitor of leucin-rich repeat kinase 2 (LRRK2) with IC50 = 0.76 nM and …
Formula:
C21H25N5O2
Purity:
Min. 98 Area-%
Color and Shape:
Powder
Molecular weight:
379.46 g/mol
Ref: 3D-FD157083
| 2mg | 165.00 € | |
| 5mg | 283.00 € | |
| 10mg | 406.00 € | |
| 25mg | 753.00 € | |
| 50mg | 1,296.00 € |
Estimated delivery in United States, on Friday 31 May 2024
MLi-2
Controlled ProductCAS:1627091-47-7
Formula:
C21H25N5O2
Color and Shape:
Neat
Molecular weight:
379.455
Ref: TR-M425473
| 25mg | 20,138.00 € |
Estimated delivery in United States, on Tuesday 2 Jul 2024
